Transfer Membrane Market Report and Forecast 2025-2034
Description
The global transfer membrane market size was valued at USD 494.50 Million in 2024, driven by the increasing investment in drug development across the globe. The market is expected to grow at a CAGR of 4.40% during the forecast period of 2025-2034, with the values likely to rise to USD 760.63 Million by 2034.
Transfer Membrane: Introduction
A transfer membrane is used in molecular biology and biochemistry techniques to transfer proteins, DNA, RNA, or other biological elements from a gel matrix to a solid support so that further detection and analysis may be performed. It is also known as a blotting membrane. Transfer membranes are available in different pore sizes, which may differ based on molecule being transferred. It can be made of nitrocellulose or PDVF, as they compatible with protein and nucleic acid bindings. The gel electrophoresis process plays a critical role in transfer membrane process.
Global Transfer Membrane Market Analysis
After the COVID-19 outbreak, the demand for diagnostic tests has significantly increased. The rising investments to expediate drug and vaccine development has seen an upswing, accredited to high occurrence of genetic diseases. As a result, the transfer membrane market value has grown owing to its crucial involvement in the study of diseases, drug development as well as diagnostic tests.
The transfer membranes hold immense significance in pharmaceutical industry for protein purification and analysis. This has led to novel innovations, aimed at fostering quality outcomes. One such common example is the launch of Immobilon® NOW by Merck. This is a transfer membrane roll which allows features like single-cut convenience, minimal waste, compact packaging to save space in the research lab and compatibility with mini or midi gels.
As per research, it has been indicated that PVDF membrane type has more advantages over nitrocellulose. They are compatible with several detection chemistries including chemogenic, radioactive, fluorescent, and chemiluminescent techniques. Therefore, to meet the high demand, Merck has four different types of PVDF membranes under the Immobilon® membranes section. These membranes offer high protein binding and durability, which is set to cater to the high transfer membrane market demand in upcoming years.
Global Transfer Membrane Market Segmentations
The EMR’s report titled “Global Transfer Membrane Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type:
North America, specifically the United States, has been dominating the transfer membrane market share. This considerable share may be accredited to the existence of a well-established research infrastructure and growing government investments in the pharmaceutical domain. Moreover, the presence of pioneer biotechnology and pharmaceutical companies, along with academic and research institutions also aid the growth of the market. Having a robust public healthcare system, Europe is second in line to lead the market share in forecast period.
Due to high population growth, government initiatives, and private investments, the Asia Pacific region is anticipated to achieve rapid transfer membrane market growth in the future. The governments are gradually prioritising the high importance of medical research and development and working towards developing a technically enhanced infrastructure for effective research work. Furthermore, the private sector is booming with the advent of foreign investment. Pharma and biotech giants have started establishing their headquarters in the Asia Pacific region to leverage the academic talent along with the easy availability of other resources.
Global Transfer Membrane Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Transfer Membrane: Introduction
A transfer membrane is used in molecular biology and biochemistry techniques to transfer proteins, DNA, RNA, or other biological elements from a gel matrix to a solid support so that further detection and analysis may be performed. It is also known as a blotting membrane. Transfer membranes are available in different pore sizes, which may differ based on molecule being transferred. It can be made of nitrocellulose or PDVF, as they compatible with protein and nucleic acid bindings. The gel electrophoresis process plays a critical role in transfer membrane process.
Global Transfer Membrane Market Analysis
After the COVID-19 outbreak, the demand for diagnostic tests has significantly increased. The rising investments to expediate drug and vaccine development has seen an upswing, accredited to high occurrence of genetic diseases. As a result, the transfer membrane market value has grown owing to its crucial involvement in the study of diseases, drug development as well as diagnostic tests.
The transfer membranes hold immense significance in pharmaceutical industry for protein purification and analysis. This has led to novel innovations, aimed at fostering quality outcomes. One such common example is the launch of Immobilon® NOW by Merck. This is a transfer membrane roll which allows features like single-cut convenience, minimal waste, compact packaging to save space in the research lab and compatibility with mini or midi gels.
As per research, it has been indicated that PVDF membrane type has more advantages over nitrocellulose. They are compatible with several detection chemistries including chemogenic, radioactive, fluorescent, and chemiluminescent techniques. Therefore, to meet the high demand, Merck has four different types of PVDF membranes under the Immobilon® membranes section. These membranes offer high protein binding and durability, which is set to cater to the high transfer membrane market demand in upcoming years.
Global Transfer Membrane Market Segmentations
The EMR’s report titled “Global Transfer Membrane Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type:
- Nylon
- Nitrocellulose
- PVDF
- Semi-dry Electrotransfer
- Dry Electrotransfer
- Tank Electrotransfer
- Amino Acid and Protein Sequencing Analysis
- Southern Blotting
- Northern Blotting
- Western Blotting
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America, specifically the United States, has been dominating the transfer membrane market share. This considerable share may be accredited to the existence of a well-established research infrastructure and growing government investments in the pharmaceutical domain. Moreover, the presence of pioneer biotechnology and pharmaceutical companies, along with academic and research institutions also aid the growth of the market. Having a robust public healthcare system, Europe is second in line to lead the market share in forecast period.
Due to high population growth, government initiatives, and private investments, the Asia Pacific region is anticipated to achieve rapid transfer membrane market growth in the future. The governments are gradually prioritising the high importance of medical research and development and working towards developing a technically enhanced infrastructure for effective research work. Furthermore, the private sector is booming with the advent of foreign investment. Pharma and biotech giants have started establishing their headquarters in the Asia Pacific region to leverage the academic talent along with the easy availability of other resources.
Global Transfer Membrane Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific, Inc.
- Danaher
- Bio-Rad Laboratories
- Merck KGaA
- PerkinElmer, Inc.
- Abcam Plc.
- ATTO Corporation
- Santa Cruz Biotechnology, Inc.
- Azure Bio systems Inc.
- Advansta Inc.
- GVS S.p.A.
- GE Healthcare
- Axiva Sichem Biotech
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Transfer Membrane Market Overview
- 3.1 Global Transfer Membrane Market Historical Value (2018-2024)
- 3.2 Global Transfer Membrane Market Forecast Value (2025-2034)
- 4 Global Transfer Membrane Market Landscape
- 4.1 Global Transfer Membrane Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Transfer Membrane Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Transfer
- 4.2.3 Analysis by Application
- 5 Global Transfer Membrane Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Transfer Membrane Market Segmentation
- 6.1 Global Transfer Membrane Market by Type
- 6.1.1 Market Overview
- 6.1.2 Nylon
- 6.1.3 Nitrocellulose
- 6.1.4 PVDF
- 6.2 Global Transfer Membrane Market by Transfer
- 6.2.1 Market Overview
- 6.2.2 Semi-dry Electrotransfer
- 6.2.3 Dry Electrotransfer
- 6.2.4 Tank Electrotransfer
- 6.3 Global Transfer Membrane Market by Application
- 6.3.1 Market Overview
- 6.3.2 Amino Acid and Protein Sequencing Analysis
- 6.3.3 Southern Blotting
- 6.3.4 Northern Blotting
- 6.3.5 Western Blotting
- 6.4 Global Transfer Membrane Market by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical and Biotechnology Companies
- 6.4.3 Diagnostic Laboratories
- 6.4.4 Academic and Research Institutes
- 6.4.5 Others
- 6.5 Global Transfer Membrane Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Transfer Membrane Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Transfer Membrane Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Transfer Membrane Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Transfer Membrane Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Transfer Membrane Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Thermo Fisher Scientific, Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Danaher
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Bio-Rad Laboratories
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Merck KGaA
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 PerkinElmer, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Abcam Plc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 ATTO Corporation
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Santa Cruz Biotechnology, Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Azure Bio systems Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Advansta Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 GVS Filter TS.p.A.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 GE Healthcare
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Axiva Sichem Biotech
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Transfer Membrane Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
